Stock Screener App

Gratuito -

Installare

1.5865

1.05% 0.0165

Bionexus Gene Lab Corp (BGLC)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Bionexus Gene Lab Corp Borsa (BGLC) Ultime notizie

11 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga

Jook Yuen Low Net Worth (2026) - GuruFocus

Set Fui Chong Net Worth (2026) - GuruFocus

Fidelion Diagnostics Pte. Ltd. Net Worth (2026) - GuruFocus

Bin Abdul Hamid Muhammad Azrul Net Worth (2026) - GuruFocus

BioNexus Gene Lab Revenue Collapses 97% in Q2 as Major Customer Lost - Minichart

BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake - Stock Titan

BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares - Stock Titan

BioNexus Gene Lab Corp (BGLC) director receives 32,258-share fully vested award - Stock Titan

BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award - Stock Titan

BioNexus Gene Lab Corp (BGLC) CFO receives 96,774-share equity award - Stock Titan

BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award - Stock Titan

BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com

BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget

Fidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares - Stock Titan

BioNexus Gene Lab Corp (BGLC) Stock News Today - TradingKey

BioNexus Gene Lab (BGLC) Surges 8.3% to $1.43: Can Momentum Break the $1.50 Ceiling?Gap Down Bounce Plays - dars.gov.et

BioNexus Gene Lab (BGLC) director discloses 1,261 common shares in Form 3 - Stock Titan

BioNexus Gene Lab (BGLC) director files Form 3 with zero shares - Stock Titan

BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan

BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey

BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey

BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView

BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey

BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey

TradingKey - TradingKey

BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

BGLC|BioNexus Gene Lab Corp|Price:1.613|Chg%:-0.027 - TradingKey

BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

BioNexus Gene Lab Corp (BGLC) Edges Higher with Micro-Advance, Testing Key Resistance ZoneNews Sentiment - dars.gov.et

BioNexus Gene Lab (BGLC) Declines 2.35% – Support at $1.58 in FocusDollar Neutral Pair - Vinanet

12 Industrials Stocks Moving In Thursday's Pre-Market SessionEos Energy Enterprises, Inc.Right (NAS - Benzinga

Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView

Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView

Number of shareholders of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView

BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Test Key ResistanceMoney Flow Index - dars.gov.et

Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView

BioNexus Gene Lab Company Profile & Introduction - Moomoo

Price to earnings forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView

Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView

AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI

BioNexus Gene Lab Corp (BGLC) Slips 6.95% as Shares Test Key Support LevelsGEX Level - Město Břeclav

BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey

BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey

BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Hold Above Key Support at $2.47Channel Breakout - newsline.com

BioNexus Gene Lab Corp (BGLC) Slips 4.1%: Testing Key Support at $2.09Elliott Wave Entry - newsline.com

BioNexus Gene Lab Calls for Malaysia–China Biotech Co-Development and Precision Healthcare Collaboration 1 - Minichart

BioNexus Gene Lab Urges Malaysia–China Co-Development of Biotech Platforms After Kuala Lumpur Forum - TradingView

BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model - Stock Titan

BioNexus Gene Lab Corp (BGLC) Slips 2.37% as Stock Tests Key Support AreaAscending Triangle - DonanımHaber

WLK

$78.85

0.76%

RPM

$110.31

1.21%

ALB

$134.19

0.07%

IFF

$83.39

0.07%

LYB

$68.10

3.09%

SQM

$78.45

4.07%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters